UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Research and development, 2025
- $550M
- YoY, 2025
- +14.3%
- 5-year CAGR
- +9.0%
- 10-year CAGR
- +8.4%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $550M | +14.3% |
| 2024 | $481M | +17.9% |
| 2023 | $408M | +26.4% |
| 2022 | $323M | −40.2% |
| 2021 | $540M | +51.0% |
| 2020 | $358M | −69.8% |
| 2019 | $1.2B | +230.4% |
| 2018 | $358M | +35.3% |
| 2017 | $265M | +79.3% |
| 2016 | $148M | −39.8% |
| 2015 | $245M | +1.1% |
| 2014 | $243M | −19.0% |
| 2013 | $299M | +72.6% |
| 2012 | $173M | −3.7% |
| 2011 | $180M | +8.9% |
| 2010 | $165M | +37.3% |
| 2009 | $120M | −49.7% |
| 2008 | $239M | — |